tag:blogger.com,1999:blog-14782375737720537302024-03-13T08:13:26.076-04:00SCIREQ Inc.SCIREQ Scientific Respiratory Equipment Inc. has been specializing in the conception, design and manufacture of precision laboratory equipment for preclinical pulmonary research since 1997. Our dedicated team of engineers and scientists develops sophisticated scientific tools that yield reproducible data of unsurpassed accuracy and detail.SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.comBlogger129125tag:blogger.com,1999:blog-1478237573772053730.post-13343191208128392452018-10-04T15:50:00.002-04:002018-10-04T15:50:24.783-04:00SCIREQ Blog has moved!<br />
<div class="MsoNormal" style="text-align: left;">
Thank you for following the SCIREQ Blog. </div>
<br />
<div class="MsoNormal" style="text-align: left;">
<br /></div>
<div class="MsoNormal" style="text-align: left;">
We moved our Blog to a new portal and invite you to continue reading our posts and stay informed about:<br />
<br />
<span style="color: #006bb3; font-family: "Segoe UI", sans-serif; font-size: 12pt; text-indent: -18pt;"> »<span style="font-family: "Times New Roman"; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">
</span></span><span style="text-indent: -18pt;">Events & User Group Meetings</span><br />
<span style="color: #006bb3; font-family: "Segoe UI", sans-serif; font-size: 12pt; text-indent: -18pt;"> »<span style="font-family: "Times New Roman"; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">
</span></span><span style="text-indent: -18pt;">Products Developments</span><br />
<span style="color: #006bb3; font-family: "Segoe UI", sans-serif; font-size: 12pt; text-indent: -18pt;"> »<span style="font-family: "Times New Roman"; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">
</span></span><span style="text-indent: -18pt;">Recent Publications</span><br />
<span style="color: #006bb3; font-family: "Segoe UI", sans-serif; font-size: 12pt; text-indent: -18pt;"> »<span style="font-family: "Times New Roman"; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;"> </span></span><o:p style="text-indent: -18pt;"></o:p><span style="text-indent: -18pt;">and news from the pulmonary community.</span><br />
<span style="text-indent: -18pt;"><br /></span></div>
<div class="MsoNormal" style="text-align: left;">
<div class="MsoListParagraph" style="margin-left: 72.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;">
<br /></div>
<br />
<div class="MsoListParagraph">
Follow this link to visit <a href="https://www.scireq.com/blog/" target="_blank">SCIREQ Blog</a>!</div>
</div>
<div class="MsoNormal" style="text-align: left;">
<br /></div>
<div class="MsoNormal" style="text-align: left;">
Happy Reading!</div>
<div class="MsoNormal" style="text-align: left;">
<br /></div>
<div class="MsoNormal" style="text-align: left;">
Your SCIREQ Team </div>
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-70431890850701170392018-07-23T22:05:00.000-04:002018-07-27T08:37:01.014-04:00FASEB’s Lung Epithelium in Health and Diseases conference<div style="text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: left;">
</div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://3.bp.blogspot.com/-rQlhFqygs2U/W0OjyRV73hI/AAAAAAAABwM/bmh8XqS1p6w7rV0Qbo_Hs4hZhF6JXSYCQCLcBGAs/s1600/FASEB%2Bprogram%2Bagenda_Page_1.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" data-original-height="375" data-original-width="1600" height="91" src="https://3.bp.blogspot.com/-rQlhFqygs2U/W0OjyRV73hI/AAAAAAAABwM/bmh8XqS1p6w7rV0Qbo_Hs4hZhF6JXSYCQCLcBGAs/s400/FASEB%2Bprogram%2Bagenda_Page_1.jpg" width="400" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><br /></td></tr>
</tbody></table>
<span style="text-align: justify;">SCIREQ is proud to sponsor FASEB’s Lung Epithelium in Health and Diseases conference which will take place from July 29th to August 3rd, 2018 in St. Bonaventure, NY. The scientific research conference will bring together leading scientists and junior researchers to discuss the latest findings in the field of lung epithelium biology. </span><br />
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The conference program touches on various respiratory ailments, disease models and novel research techniques, including:</div>
<br />
<ul>
<li style="text-align: justify;">Mucociliary transport in cystic fibrosis (Michael Welsh, University of Iowa)</li>
<li style="text-align: justify;">Lung development and regeneration (Jeffrey Whitsett, Cincinnati Children’s; Bernard Thébaud, University of Ottawa)</li>
<li style="text-align: justify;">Neuroendocrine Hyperplasia of Infancy (Lisa Young, Vanderbilt University)</li>
<li style="text-align: justify;">Disease modelling with organoid culture systems and cryopreserved human lung slices (Xingbin Ai, Brigham & Women’s Hospital; Barry Stripp, Cedars-Sinai)</li>
<li style="text-align: justify;">Genetics and Genomics of Lung Diseases (Steve Rowe , U.of Alabama; David Schwartz, U.of Colorado)</li>
<li>And many other topics</li>
</ul>
<br />
<b>Links:</b><br />
Program:<span style="white-space: pre;"> </span><a href="https://secure.faseb.org/src-programs/11508.pdf" target="_blank">https://secure.faseb.org/src-programs/11508.pdf </a><br />
Conference website: <a href="http://faseb.org/src/micro/Site/Lung/Home.aspx" target="_blank">http://faseb.org/src/micro/Site/Lung/Home.aspx </a><br />
<br />
We look forward to talks, poster sessions and new collaboration opportunities that will emerge from the FASEB event.<br />
<br />SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-62643289212356979462018-07-05T08:31:00.000-04:002018-07-05T08:31:20.022-04:00Bronchopulmonary Dysplasia (BPD) after 50 years – BPD Symposium at Stanford<div style="text-align: justify;">
A momentous symposium was held at Stanford university last year to commemorate the 50<sup><span style="font-family: "calibri" , sans-serif; line-height: 107%;"><span style="font-size: xx-small;">th</span></span></sup> anniversary since the original description of Bronchopulmonary Dysplasia (BPD) was first articulated<span style="font-size: xx-small;"><span style="font-family: "calibri" , sans-serif; vertical-align: super;">1</span> </span>by Dr. William Northway and him team in 1967. </div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-7G_krio_Kyk/WzZIB9GnEEI/AAAAAAAABv0/yRg2OiMZF3UgfxYQSsxTE5dXMzdXtQqDwCLcBGAs/s1600/blog%2BBPD.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="329" data-original-width="754" height="172" src="https://4.bp.blogspot.com/-7G_krio_Kyk/WzZIB9GnEEI/AAAAAAAABv0/yRg2OiMZF3UgfxYQSsxTE5dXMzdXtQqDwCLcBGAs/s400/blog%2BBPD.png" width="400" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
This symposium, which was attended by several leaders in the field, was held as a platform where researchers could come together and highlight the progress that has been made to date, along with discuss future perspectives. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The event was divided into 5 sessions with keynote presentations provided by speakers who have made noteworthy contributions in the field of BPD. We are proud to say that amongst such speakers were Dr. Bernard Thébaud, Dr. Rory Morty and Dr. Rob Tepper, who gave very informed and thought provoking lectures during the symposium, are active users of our SCIREQ systems!</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
We would like to extend our <b>Thank You</b> to all investigators who constantly strive towards making new strides in this field of preclinical pediatric research.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Learn more about how <a href="http://www.scireq.com/products-overview" target="_blank">SCIREQ’s solutions</a> can be implemented into your research needs or how our instruments are being utilized to study <a href="http://blog.scireq.com/2017/05/bronchopulmonary-dysplasia.html" target="_blank">Bronchopulmonary Dysplasia</a>. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<span style="font-family: "calibri" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span><span style="font-size: x-small;">Northway et. al. Pulmonary Disease Following Respirator Therapy of Hyaline-Membrane Disease — Bronchopulmonary Dysplasia, N Engl J Med 1967; 276:357-368</span></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-34492758646226596472018-06-22T10:56:00.005-04:002018-06-22T10:56:53.516-04:00IDEAL OR ACTUAL BODY WEIGHT OF THE OBESE SUBJECT?<h4>
When working with obese mice, what weight should be used when performing flexiVent measurements?</h4>
<div>
<br /></div>
<div>
<br /></div>
<div>
</div>
This question is quite an important one for two reasons. First, there is a substantial difference in weight between the obese subjects vs. the lean control group. For instance, obese mice can weigh 50g or more, while their age-matched control group can typically weigh 30g. While there is this significant difference in the weight between both groups, there may not be a large difference in the actual size of the subjects’ lungs.<br />
<br />
<div style="text-align: left;">
Second, when working with the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent </a>system, the body weight of the subject is used to scale the amplitude of volume-controlled ventilation patterns and perturbations, such as the Snapshot-150 or the Quick Prime-3. In obese animals, the increase in body weight is not proportional to the subject’s lung size, so sending in a larger volume can have adverse effects on the subject’s lungs.</div>
<div style="text-align: left;">
<br /></div>
<div style="text-align: left;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-ngdOlajOJwc/Wy0MvCnhOCI/AAAAAAAABvo/WCzIsPB1mqoVuLqbLX5K73bCkABImOhogCLcBGAs/s1600/obese%2Bmic.jpg" imageanchor="1" style="display: inline !important; margin-left: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="418" data-original-width="743" height="221" src="https://4.bp.blogspot.com/-ngdOlajOJwc/Wy0MvCnhOCI/AAAAAAAABvo/WCzIsPB1mqoVuLqbLX5K73bCkABImOhogCLcBGAs/s400/obese%2Bmic.jpg" width="400" /></a></div>
<br />
A recent study performed by Dr. Guivarchis et al.<span style="font-family: "Segoe UI", sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span>, highlights the harmful effects of ventilating obese subjects with a tidal volume based on actual weight vs ideal weight using the flexiVent system. In this study, the effects of two hours of mechanical ventilation in a diet-induced obese mice model, with tidal volume calculated on either the actual body weight or the ideal body weight (based on the mean weight of control mice) were demonstrated. Their findings indicate that in comparison to lean control subjects, mechanically ventilating obese subjects with a tidal volume based on actual body weight is harmful.<br />
<br />
They observed a noticeable variation in lung mechanics and associated lung inflammation in obese mice ventilated with a tidal volume based on actual body weight. In contrast, obese mice ventilated with a tidal volume calculated using the ideal body weight had lung mechanics and inflammation parameters close to the lean control group.<br />
<br />
<b>Therefore, when studies involve the assessment of obese mice, SCIREQ recommends entering the average weight of the lean control group rather than using the actual weight of the obese subjects.</b><br />
<br />
<br />
<span style="font-family: "Segoe UI", sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span><span style="font-size: x-small;">Guivarch et al. Pulmonary Effects of Adjusting Tidal Volume to Actual or Ideal Body Weight in Ventilated Obese Mice. Sci Rep. 2018 Apr 24;8(1):6439. doi: 10.1038/s41598-018-24615-5.</span><br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-90101218844842785862018-06-11T08:06:00.000-04:002018-06-11T08:06:19.186-04:00To open or close the lungs – that is the question!Although often necessary, mechanical ventilation of small animals during pulmonary measurements can lead to both acute and chronic damage to their lungs, also known as ventilator-induced lung injury (VILI). The injury happens as a result of the frequent opening and closing of alveolar air sacs. Nevertheless, the two most common, and greatly contrasting methods, to study respiratory diseases include open lung- and closed lung-approaches. This has led to many pulmonary researchers conducting experiments with the goal of determining which approach is the least harmful and the best possible way to minimize VILI.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.scireq.com/applications/ARDS" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img border="0" data-original-height="580" data-original-width="580" height="200" src="https://4.bp.blogspot.com/-Fh98GBJnn2g/Wxlk0leMBGI/AAAAAAAABvM/jK8mtX8MAlcTWvNh-pYElof8CBJlhbiIgCLcBGAs/s200/FX_ventilation.png" width="200" /></a></div>
<h4>
TO OPEN THE LUNGS?</h4>
Open-chest models are often used to study <a href="http://www.scireq.com/applications/ARDS" target="_blank">ARDS</a> and acute myocardial ischemia and reperfusion. These models allow for investigating cardiac physiology, morphological changes of the lungs, as well as the evaluation of therapeutic interventions. This procedure allows for invasive lung function measurements and tissue harvesting for further experimentation, but must be performed under deep anesthesia. Since opening the chest causes the lungs to collapse, the animals must be mechanically ventilated throughout the process.<br />
<br />
The <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a> has often been used in open-chest experiments, as the system allows for ventilation of the subject with a user-defined positive end-expiratory pressure (PEEP), which can be set to prevent airway collapse. Further, it can facilitate the complete recruitment of the lungs, using the Deep Inflation perturbation, before measurements can be taken.<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-bha-YjX5yz8/Wxln20CaviI/AAAAAAAABvY/ma5JLtoHBrY6GGnxCZKNdfSDiEGIqWpewCLcBGAs/s1600/FX%2BFEV%2Bconfiguration_computer.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="710" data-original-width="1600" height="177" src="https://2.bp.blogspot.com/-bha-YjX5yz8/Wxln20CaviI/AAAAAAAABvY/ma5JLtoHBrY6GGnxCZKNdfSDiEGIqWpewCLcBGAs/s400/FX%2BFEV%2Bconfiguration_computer.png" width="400" /></a></div>
<br />
<br />
<h4>
TO CLOSE THE LUNGS?</h4>
Recent experimental evidence suggests that high PEEP does not necessarily reduce lung injury but instead, may lead to the contrary. Higher PEEP results in overstretching the alveolar sacs and potential development of edema, among other cardiopulmonary impairment. Moreover, a recent article by Dr. Patricia Rocco and team<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span>, points out that most publications comparing high PEEP with no PEEP, do so with a combination of low tidal volume and high tidal volume, respectively. Thus, there is no clear indication as to what exactly led to the observed outcomes – high PEEP or low tidal volume.<br />
<br />
Dr. Rocco goes on to recommend “in order to minimize VILI, we should consider moving away from the classical concept of ‘open up the lungs and keep them open’ towards ‘close down the lungs and keep them closed’”. Fortunately, the flexiVent can be adapted to different experimental conditions, and can provide detailed <a href="http://www.scireq.com/flexivent/techniques-and-measurements" target="_blank">pulmonary measurements</a> even as research trends change.<br />
<br />
<br />
<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span>Pelosi, P. et al. 2018. <a href="https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-1991-3" target="_blank">Close down the lungs and keep them resting to minimize ventilator-induced lung injury.</a> Critical Care 22 (1):72.<br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-84811074274138407522018-05-14T13:10:00.000-04:002018-05-14T14:06:44.615-04:00Must see posters at ATS!ATS is just around the corner and we hope to see you in San Diego!<br />
<br />
<div class="MsoNormal" style="margin-bottom: .0001pt; margin: 0cm;">
We are looking
forward to learning more about respiratory research, especially these
interesting flexiVent poster sessions:<o:p></o:p></div>
<br />
<ul>
<li>A1423 / P953 - <a href="http://www.abstractsonline.com/pp8/#!/4499/presentation/12083" target="_blank">Preclinical Experiments Support Recent Clinical Switch to Delivered Dose During Methacholine Bronchoprovocation Testing</a> - O. Schmid, W. Moeller, A. Stelzl, J. Lund, A. O. Yildirim, S. Krauss-Etschmann, A. Robichaud</li>
<li>A5035 / P1420 - <a href="http://www.abstractsonline.com/pp8/#!/4499/presentation/13798" target="_blank">A Ventilation Strategy to Target Blocked Regions of a Symmetric Lung Structure During Aerosolized Particle Delivery </a>– A. H. Sonnenberg, E. Taylor, M. Grinstaff, B. Suki</li>
<li>A5801 / P51 - <a href="http://www.abstractsonline.com/pp8/#!/4499/presentation/9663" target="_blank">Relationship Between Allergen Challenge, Lung Inflammation and Lung Dysfunction in Murine Models of Asthma</a> - S. Basu, C. Pascoe, A. Jha, J. Schwartz, A. J. Halayko</li>
</ul>
During our <b>annual breakfast event at ATS</b> on Monday, May 21st, Dr. Otmar Schmid (Helmholtz Zentrum, Germany) will discuss his “off-label” use of the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a> for the delivery of inhaled compounds. By optimizing the ventilation profiles and nebulizer settings, Dr. Schmid and Dr. Annette Robichaud obtained significant improvements in aerosol deposition rates, as well as homogenous deposition profiles.<br />
<br />
<div>
<div>
</div>
<div>
The technique developed by Dr.Schmid could be useful in studies for optimized inhaled drug delivery using the flexiVent. If you are interested, please feel free to join us by <a href="http://www.scireq.com/scireq-breakfast-event-ats-2018" target="_blank">registering here.</a><br />
<br />
We would love to learn more about your research and discuss some tailored solutions. Find us at <b>Booth #1535 in Exhibit Hall D</b>.<br />
<div class="separator" style="clear: both; text-align: left;">
<br /></div>
<div class="separator" style="clear: both; text-align: left;">
<b>Exhibit Hours</b></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
Sunday, May 20 10:30 am – 3:30 pm<br />
Monday, May 21 10:30 am – 3:30 pm<br />
Tuesday, May 22 10:30 am – 3:30 pm<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<br /></div>
</div>
<div>
<br /></div>
<div>
<br /></div>
<br />SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-78501669123641073372018-04-16T12:00:00.000-04:002018-04-16T12:09:11.875-04:00Cardiopulmonary Solutions by emka & SCIREQ<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-ER7l0V-mQ7M/Wr0wIJslGLI/AAAAAAAABr0/kFmvSXUJtfc4fRlyso5XV3Zp0VrGqzKmgCEwYBhgL/s1600/cardiopulmonary_real.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="148" data-original-width="131" src="https://4.bp.blogspot.com/-ER7l0V-mQ7M/Wr0wIJslGLI/AAAAAAAABr0/kFmvSXUJtfc4fRlyso5XV3Zp0VrGqzKmgCEwYBhgL/s1600/cardiopulmonary_real.png" /></a></div>
emka & SCIREQ offer a unique perspective into the preclinical study of heart and lung diseases, allowing for novel insights into cardiopulmonary diseases such as heart failure, arrhythmia, COPD, pulmonary hypertension and more.<br />
<br />
Will you be attending the <b>Experimental Biology</b> meeting in San Diego next week? If so, visit<b> booth #1624</b> to learn more about our range of cardiopulmonary solutions, including:<br />
<br />
<div style="text-align: justify;">
<b>Model Development with the <a href="http://www.scireq.com/inexpose" target="_blank">inExpose</a>:</b></div>
<div style="text-align: justify;">
</div>
<ul>
<li style="text-align: left;">In vivo disease models that mimic complex pathophysiological mechanisms of cardiopulmonary diseases using the inExpose, an automated platform for reproducible inhalation exposure (1,2)</li>
<li style="text-align: left;">Smoke-induced alterations in cardiac and respiratory function through cigarette or e-cigarette exposure (3,4)</li>
<li style="text-align: left;">Effective drug intervention for both preclinical subjects and cell culture exposures through aerosols (5,6).</li>
</ul>
<b>Respiratory Mechanics Measurements with the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a>:</b><br />
<ul>
<li style="text-align: left;">Studying the underlying pathophysiology of cardiopulmonary diseases by measuring the structure and function of the lung, along with quantifying the effects of pulmonary hypertension and decreased vascularization with the flexiVent (7,8,9).</li>
<li style="text-align: left;">Pressure-volume manoeuvres, forced expired volume and other endpoints of clinical translational value performed by the flexiVent (10,11).</li>
</ul>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div>
<br /></div>
<b>High-throughput Screening Using <a href="http://www.scireq.com/plethysmographs" target="_blank">Whole Body Plethysmography</a></b><br />
<ul>
<li style="text-align: left;">Whole Body Plethysmography can be an easy tool for screening subjects quickly for preliminary respiratory data with the option of delivering inhaled therapeutics (12,13,14).</li>
<li style="text-align: left;">Easy integration with simultaneous cardio and neuro recordings: electroencephalogram (EEG), electrocardiogram (ECG) & electromyogram (EMG).</li>
</ul>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div>
<br /></div>
<b>Wireless Biopotential Monitoring using <a href="http://www.emka.fr/technology/implanted-telemetry/" target="_blank">Implantable Telemetry</a></b><br />
<ul>
<li style="text-align: left;">Monitoring physiological data from conscious freely moving rodents and large animals using easyTEL implantable telemetry systems. Different models are available to meet your study needs and provide monitoring of ECG, EEG, blood pressure, breathing rate, temperature and acceleration from 3-axis accelerometer (activity).</li>
</ul>
<div>
<br /></div>
<b>Exhibit Hours - Booth 1624</b><br />
Sunday, April 22nd <span style="white-space: pre;"> </span>9:00am – 4pm<br />
Monday, April 23rd <span style="white-space: pre;"> </span>9:00am – 4pm<br />
Tuesday, April 24th <span style="white-space: pre;"> </span>9:00am – 4pm<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-I_ydNbjpejU/Wr00q1f2u-I/AAAAAAAABsA/2CrGGI-4ghsZ6tdp6BsBfnFqnOARA7PDACLcBGAs/s1600/EB%2Bfloorplan%2B1624.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="992" data-original-width="1600" height="246" src="https://2.bp.blogspot.com/-I_ydNbjpejU/Wr00q1f2u-I/AAAAAAAABsA/2CrGGI-4ghsZ6tdp6BsBfnFqnOARA7PDACLcBGAs/s400/EB%2Bfloorplan%2B1624.jpg" width="400" /></a></div>
<br />
<a href="mailto:events@scireq.com" target="_blank">Click here</a> to set-up a meeting to learn more about our solutions for cardiopulmonary studies.<br />
<br />
<h4>
References</h4>
<span style="font-size: x-small;">1)<span style="white-space: pre;"> </span>Weist, E.F., et al. (2017). Omega-3 Polyunsaturated Fatty Acids Protect Against Cigarette Smoke-Induced Oxidative Stress and vascular Dysfunction. Toxicological Sciences, 156(1): 300-310</span><br />
<span style="font-size: x-small;">2)<span style="white-space: pre;"> </span>Tewari et al. (2011). Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS. Proteomics, 11: 2051, 2011.</span><br />
<span style="font-size: x-small;">3)<span style="white-space: pre;"> </span>Olfert, M. et al. (2018). Chronic exposure to electronic cigarette results in impaired cardiovascular function in mice. J of Applied Physiology, 124(3): 573-582</span><br />
<span style="font-size: x-small;">4)<span style="white-space: pre;"> </span>Alasmari F, Crotty Alexander LE, Nelson JA, et al. (2017). Effects of Chronic Inhalation of Electronic Cigarettes Containing Nicotine on Glial Glutamate Transporters and α-7 Nicotinic Acetylcholine Receptor in Female CD-1 Mice. Vol 77. Elsevier Inc</span><br />
<span style="font-size: x-small;">5)<span style="white-space: pre;"> </span>Patolla et al. (2010). Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release. 144: 233-241</span><br />
<span style="font-size: x-small;">6)<span style="white-space: pre;"> </span>De Santis, et al. (2014). Pharmaceutical composition of oxidised avidin suitable for inhalation - De Santis. U.S. patent application 14/236,445</span><br />
<span style="font-size: x-small;">7)<span style="white-space: pre;"> </span>Alsaid, H., et al. (2011). Serial MRI characterization of the functional and morphological changes in mouse lung in response to cardiac remodeling following myocardial infarction. Magnetic Resonance in Medicine, 67(1): 191-200</span><br />
<span style="font-size: x-small;">8)<span style="white-space: pre;"> </span>Dayeh, N.R et al. (2017). Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice. Scientific Reports, 1363</span><br />
<span style="font-size: x-small;">9)<span style="white-space: pre;"> </span>Karmouty-Quintana, H., et al. 2012. The A2B Adenosine Receptor Modulates Pulmonary Hypertension Associated With Interstitial Lung Disease. The FASEB Journal, 26(6): 2546-2557</span><br />
<span style="font-size: x-small;">10)<span style="white-space: pre;"> </span>Devos, F.C et al. (2017). Forced expiration measurements in mouse models of obstructive and restrictive lung diseases. Respiratory Research, 18(123)</span><br />
<span style="font-size: x-small;">11)<span style="white-space: pre;"> </span>Vanoirbeek, J. (2016). Forced Expiratory Volume (FEV) Measurements in Mouse Models of Lung Disease. American Journal of Respiratory and Critical Care Medicine, 193, A5957</span><br />
<span style="font-size: x-small;">12)<span style="white-space: pre;"> </span>Olea et al. (2011). Effects of cigarette smoke and chronic hypoxia on airways remodelling and resistance. Clinical Significance, 15; 179(2-3): 305-313</span><br />
<span style="font-size: x-small;">13)<span style="white-space: pre;"> </span>Ramnath et al. (2014). Extracellular matrix defects in aneurysmal fibulin-4 mice predispose to lung emphysema. PLOS One, 9(9): 106054</span><br />
<span style="font-size: x-small;">14)<span style="white-space: pre;"> </span>Zhuang, P., et al. (2016). cAMP-PKA-CaMKII signalling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension. Scientific Reports, 6, 34903</span><br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-11940205782700766182018-04-13T09:30:00.000-04:002018-04-16T12:09:48.069-04:00Hypoxia studies using EMKA whole-body plethysmography<div style="text-align: justify;">
<a href="https://3.bp.blogspot.com/-t9zaUwvDsIA/Wp7ifaxf4lI/AAAAAAAABqU/Sf03pRBUg5AB_lzxSHyq_0OriJoPiX4fACLcBGAs/s1600/animal%2Bicon%2Bmouse%2Bblue.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="98" data-original-width="141" src="https://3.bp.blogspot.com/-t9zaUwvDsIA/Wp7ifaxf4lI/AAAAAAAABqU/Sf03pRBUg5AB_lzxSHyq_0OriJoPiX4fACLcBGAs/s1600/animal%2Bicon%2Bmouse%2Bblue.png" /></a>Oxygen deficiency or hypoxia can contribute to the development or exacerbation of many disorders including strokes or chronic lung diseases. The first defense against hypoxia is the hypoxic ventilatory response (HVR). These cardiorespiratory reflexes, like hyperventilation or sympathetic activation, increase gas exchange in the lungs and oxygen delivery to vital organs. Genetically modified mice help researchers identify the processes involved in a hypoxic response, however in order to properly study these responses, reliable methodologies are necessary to understand changes in breathing patterns. Whole-body plethysmography is one important technique for <i>in vivo</i> assessment. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The most important chemoreceptor in mammals is the carotid body (CB), and this organ contains O2-sensing neuron-like glomus cells among others. Dr. Ortega-Sáenz’ group studied the hypoxic response in the CB by using whole-body plethysmography combined with gas mixing. They generated normoxic, hypoxic, or hypercapnic conditions to compare ventilatory responses. The <i>Ndufs2</i> gene was deleted in a genetically modified mouse (TH-NDUFS2 mouse) which removed the responsiveness to hypoxia while leaving the response to hypercapnia. In their studies, the wild-type mouse responded to hypoxia and hypercapnia with an increase in breathing frequency, while the TH-NDUFS2 mouse only mediated its response in hypercapnic conditions. Although many respiratory variables can be recorded, this group chose breathing frequency as the most reliable and informative parameter and concluded that normal O2-sensing in CB glomus cells is necessary for a normal HVR. </div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-skB4US2n-8M/Wp7ne6FpcnI/AAAAAAAABrI/HkYiWnr4HbYdBqTsh-zj_2UiJ_i_n2j8wCLcBGAs/s1600/Plethy_overview%2Bwith%2Bcomputer.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="557" data-original-width="921" height="240" src="https://4.bp.blogspot.com/-skB4US2n-8M/Wp7ne6FpcnI/AAAAAAAABrI/HkYiWnr4HbYdBqTsh-zj_2UiJ_i_n2j8wCLcBGAs/s400/Plethy_overview%2Bwith%2Bcomputer.png" width="400" /></a></div>
<div class="separator" style="clear: both; text-align: justify;">
Plethysmography is a standard method for studying pulmonary function in conscious, spontaneously breathing laboratory subjects. The barometric plethysmography technique measures flow and pressure changes that occur while the subject is breathing, before and after exposure to a drug or other challenges. It is easily adapted to various subject sizes and species, and is often used for longitudinal studies where the subjects are studied for multiple hours on successive experiment days. </div>
<div style="text-align: justify;">
<br /></div>
To learn more about, visit our website at <a href="http://www.scireq.com/plethysmographs" target="_blank">www.scireq.com/plethysmographs</a> or contact <a href="mailto:info@scireq.com">info@scireq.com</a>.<br />
<br />
<br />
<b>READ MORE</b><br />
Ortega-Sáenz, Patricia, et al. "<a href="https://link.springer.com/protocol/10.1007/978-1-4939-7665-2_13" target="_blank">Testing Acute Oxygen Sensing in Genetically Modified Mice: Plethysmography and Amperometry</a>." <i>Hypoxia</i>. Humana Press, New York, NY, 2018. 139-153.<br />
<br />
<b>CONTACT US</b><br />
Phone 1.514.286.1429 | Toll Free 1.877.572.4737<br />
Email <a href="mailto:sales@scireq.com">sales@scireq.com</a><br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-27630516047207928402018-04-02T08:00:00.000-04:002018-04-02T08:27:55.601-04:00FlexiVent – Used in Recent Pulmonary Fibrosis Research<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-TS3n8k7UOxI/Wly7Kz6b6XI/AAAAAAAABog/QI8diZ9fmPIDu_bRBTtWllfevyNgm1cTwCLcBGAs/s1600/Fibrosis1.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="580" data-original-width="580" height="200" src="https://4.bp.blogspot.com/-TS3n8k7UOxI/Wly7Kz6b6XI/AAAAAAAABog/QI8diZ9fmPIDu_bRBTtWllfevyNgm1cTwCLcBGAs/s200/Fibrosis1.jpg" width="200" /></a></div>
<div style="text-align: justify;">
Pulmonary fibrosis describes a condition in which the normal lung anatomy is replaced by a process of active remodeling, deposition of extracellular matrix and dramatic changes in the phenotype of both fibroblasts and alveolar epithelial cells. This condition can be idiopathic, as in idiopathic pulmonary fibrosis (IPF), or secondary to genetic disorders, autoimmune disorders or exposure to environmental toxins, chemical warfare, drugs, foreign antigens or radiation<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span><span style="font-family: "segoe ui" , sans-serif; font-size: 13.3333px;">.</span></div>
<div style="text-align: justify;">
<span style="font-family: "segoe ui" , sans-serif; font-size: 13.3333px;"><br /></span></div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
<b>Recent publication in Nature Medicine</b></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-GgQ1RAJ-M10/Wly8Fu_tbXI/AAAAAAAABos/okNgVdiUGnQgxzfBuUmGcGFFKTRRn_mwwCLcBGAs/s1600/FX%2Bw%2Bcomputer_animals%2B-%2BCopy.png" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="739" data-original-width="1050" height="224" src="https://4.bp.blogspot.com/-GgQ1RAJ-M10/Wly8Fu_tbXI/AAAAAAAABos/okNgVdiUGnQgxzfBuUmGcGFFKTRRn_mwwCLcBGAs/s320/FX%2Bw%2Bcomputer_animals%2B-%2BCopy.png" width="320" /></a></div>
<div style="text-align: justify;">
A research group from Yale School of Medicine (Yu, Guoying, et al.)<span style="font-size: xx-small;"><span style="font-family: "segoe ui" , sans-serif; vertical-align: super;">2</span> </span>hypothesized that the Thyroid hormone (TH) would inhibit pulmonary fibrosis by improving mitochondrial function. Thyroid hormone (TH) is known for being critical to maintaining cellular homeostasis during stress responses. In this study, fibrotic murine models were developed by injecting their mice with bleomycin and then the flexiVent was used to evaluate in vivo respiratory mechanics to assess therapeutic efficacy of TH in their murine models. Results showed that TH has antifibrotic properties and may present a potential therapy for pulmonary fibrosis. These great findings were recently published in <a href="https://www.nature.com/articles/nm.4447" target="_blank">Nature Medicine</a>.</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<b>flexiVent – used across many pulmonary applications </b><br />
<div style="text-align: justify;">
<a href="https://1.bp.blogspot.com/-zXNm3KdoQMQ/Wly8ZErRRrI/AAAAAAAABow/lu1x6nJSbnMgX4_tMsKwrechzv892SjiACLcBGAs/s1600/imaging%2B1.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="502" data-original-width="756" height="211" src="https://1.bp.blogspot.com/-zXNm3KdoQMQ/Wly8ZErRRrI/AAAAAAAABow/lu1x6nJSbnMgX4_tMsKwrechzv892SjiACLcBGAs/s320/imaging%2B1.jpg" width="320" /></a>Pulmonary fibrosis in humans is typically diagnosed using computed tomography (CT) scans and pulmonary function tests, both of which can be performed in small laboratory animals using the flexiVent. The system can synchronize with micro-CT scanners to reduce motion artifacts, and be used separately to provide static and dynamic measurements of respiratory mechanics, as well as to capture information on specific lung volumes or flows. All these features make the flexiVent a valuable and comprehensive tool to investigate pulmonary fibrosis at the preclinical level. </div>
<br />
To learn more about this system, please visit our website at <a href="http://www.scireq.com/flexivent">www.scireq.com/flexivent</a>.<br />
<br />
<br />
<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span><span style="font-size: x-small;">Travis, W.D. et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188, 733–748 (2013).</span><br />
<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">2</span></span><span style="font-size: x-small;">Yu, Guoying, et al. "Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function." Nature medicine (2017).</span><br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-54096500001835012292018-03-28T13:17:00.003-04:002018-03-28T13:21:46.157-04:00Why should you and your team join us for the flexiVent User Group Meeting in San Diego on 26th April 2018:<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>This is a <b>free</b> User Group Meeting.</div>
<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>It is <b>open</b> to everyone interested in respiratory research with the flexiVent.</div>
<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>It is beneficial for <b>current </b>flexiVent users and <b>newcomers</b> to </div>
<div style="text-align: justify;">
SCIREQ’s research equipment.</div>
<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>It will <b>refresh</b> your knowledge of key aspects of flexiVent experimentation </div>
<div style="text-align: justify;">
and <b>learn</b> how others use the flexiVent.</div>
<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>You will have the chance to ask flexiVent experts <b>your questions</b>.</div>
<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>It is a <b>networking</b> opportunity for respiratory researchers.</div>
<div style="text-align: justify;">
»<span style="white-space: pre;"> </span>You will connect with potential future <b>collaborators</b>.</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://3.bp.blogspot.com/-VrNSGXBoOjI/WrvPBL45L0I/AAAAAAAABrc/BalqGGq7fbQd6ei2Q33a1NP5uvREDgyxgCLcBGAs/s1600/FX%2Bw%2Bcomputer_animals%2B-%2BCopy.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="739" data-original-width="1050" height="281" src="https://3.bp.blogspot.com/-VrNSGXBoOjI/WrvPBL45L0I/AAAAAAAABrc/BalqGGq7fbQd6ei2Q33a1NP5uvREDgyxgCLcBGAs/s400/FX%2Bw%2Bcomputer_animals%2B-%2BCopy.png" width="400" /></a></div>
<br />
<br />
Please complete your <a href="http://www.scireq.com/flexivent-user-group-meeting-san-diego-2018-registration" target="_blank">REGISTRATION HERE</a> and be part of this event.<br />
<br />
<b>WHEN:</b> Thursday April 26, 2018<br />
<b>WHERE:</b> San Diego, California (Hilton San Diego Bayfront)<br />
<br />
<b>AGENDA:</b><span style="white-space: pre;"> </span>9:00<span style="white-space: pre;"> </span> Registration<br />
<span style="white-space: pre;"> </span> 9:30<span style="white-space: pre;"> </span> Welcome & Introduction<br />
<span style="white-space: pre;"> </span> 9:45<span style="white-space: pre;"> </span> Presentations:<br />
»<span style="white-space: pre;"> </span>SCIREQ flexiVent to Measure Respiratory Mechanics<br />
»<span style="white-space: pre;"> </span>Troubleshooting flexiVent Data<br />
»<span style="white-space: pre;"> </span>Aspects of Preclinical Lung Function Measurement<br />
»<span style="white-space: pre;"> </span>Product-Related Considerations<br />
»<span style="white-space: pre;"> </span>Full-Range PV curves and Lung Volumes<br />
»<span style="white-space: pre;"> </span>Current flexiVent User Presentations<br />
<span style="white-space: pre;"> </span> 16:00 Closing Remarks<br />
<br />
If you are interested in presenting your pulmonary research with the flexiVent during this user group, do not hesitate to contact us as soon as possible, to include your presentation in the agenda.<br />
<br />
If you have any questions, do not hesitate to contact us at <a href="mailto:events@scireq.com">events@scireq.com</a> or toll-free at 1-877-572-4737.<br />
<br />
We look forward to seeing you in San Diego!<br />
<br />
Your SCIREQ Team<br />
<br />SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-12020990581520766402018-03-19T09:15:00.000-04:002018-03-19T09:36:52.492-04:00A step in moving towards the low frequency range<div style="text-align: justify;">
In clinical medicine, spirometry continues to dominate as the pulmonary function test of choice. This is despite the issues which limit its utility, largely patient compliance and the limited inferences which can be made regarding the mechanical properties of the respiratory system. Alternatively, the forced oscillation technique (FOT), utilized by the <a href="http://www.scireq.com/flexivent" target="_blank"><b>flexiVent</b></a> preclinically, is well-known for its rich description of the mechanical properties of the respiratory system. However, despite becoming the gold-standard in preclinical research, the approach has yet to make significant in-roads into the clinical domain, especially in the low frequency range (0-2 Hz) that gives access to the peripheral lung, the area most sensitive to pathological changes.<br />
<br />
In ventilated patients FOT solutions do exist, however free-breathing patients present obstacles as accurate measurements of the respiratory system rely on precise measurements of pressure and flow. Potential solutions to this problem have been trialed, for instance training patients to perform voluntary apnea<!--[if supportFields]><span style='font-size:10.0pt;
mso-bidi-font-size:11.0pt;font-family:"Segoe UI","sans-serif";mso-fareast-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:Calibri;
color:windowtext;mso-ansi-language:EN-CA;mso-fareast-language:EN-CA;mso-bidi-language:
AR-SA'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN
CSL_CITATION { "citationItems" : [ { "id" :
"ITEM-1", "itemData" : { "ISSN" :
"8750-7587", "PMID" : "2935519",
"abstract" : "Respiratory mechanical impedances were determined
during voluntary apnea in five healthy subjects, by means of 0.25- to 5-Hz
pseudo/random oscillations applied at the mouth. The total respiratory
impedance was partitioned into pulmonary (ZL) and chest wall components with
the esophageal balloon technique; corrections were made for the upper airway
shunt impedance and the compressibility of alveolar gas. Neglect of these shunt
effects did not qualitatively alter the frequency dependence of impedances but
led to underestimations in impedance, especially in the chest wall resistance
(Rw), which decreased by 20-30% at higher frequencies. The total resistance
(Rrs) was markedly frequency dependent, falling from 0.47 +/- 0.06 (SD) at 0.25
Hz to 0.17 +/- 0.01 at 1 Hz and 0.15 +/- 0.01 kPa X l-1 X s at 5 Hz. The
changes in Rrs were caused by the frequency dependence of Rw almost exclusively
between 0.25 and 2 Hz and in most part between 2 and 5 Hz. The effective total
respiratory (Crs,e) and pulmonary compliance were computed with corrections for
pulmonary inertance derived from three- and five-parameter model fittings of
ZL. Crs,e decreased from the static value (1.03 +/- 0.18 l X kPa-1) to a level
of approximately 0.35 l X kPa-1 at 2-3 Hz; this change was primarily caused by
the frequency-dependent behavior of chest wall compliance.",
"author" : [ { "dropping-particle" : "",
"family" : "Hantos", "given" : "Z",
"non-dropping-particle" : "", "parse-names" :
false, "suffix" : "" }, { "dropping-particle" :
"", "family" : "Dar\u00f3czy", "given"
: "B", "non-dropping-particle" : "",
"parse-names" : false, "suffix" : "" }, {
"dropping-particle" : "", "family" :
"Suki", "given" : "B", "non-dropping-particle"
: "", "parse-names" : false, "suffix" :
"" }, { "dropping-particle" : "",
"family" : "Galg\u00f3czy", "given" :
"G", "non-dropping-particle" : "",
"parse-names" : false, "suffix" : "" }, {
"dropping-particle" : "", "family" :
"Csendes", "given" : "T",
"non-dropping-particle" : "", "parse-names" :
false, "suffix" : "" } ], "container-title" :
"Journal of applied physiology (Bethesda, Md. : 1985)",
"id" : "ITEM-1", "issue" : "1",
"issued" : { "date-parts" : [ [ "1986",
"1" ] ] }, "page" : "123-32", "title" :
"Forced oscillatory impedance of the respiratory system at low
frequencies.", "type" : "article-journal",
"volume" : "60" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=81dc0d85-3730-3280-be8e-ebe61c4ce676"
] } ], "mendeley" : { "formattedCitation" :
"<sup>1</sup>", "plainTextFormattedCitation" :
"1", "previouslyFormattedCitation" :
"<sup>1</sup>" }, "properties" : {<span
style='mso-spacerun:yes'> </span>}, "schema" :
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"
}<span style='mso-element:field-separator'></span></span><![endif]--><span style="color: windowtext; font-family: "segoe ui" , sans-serif;"><sup><span style="font-size: xx-small;">1</span></sup></span><!--[if supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Segoe UI","sans-serif";
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:
Calibri;color:windowtext;mso-ansi-language:EN-CA;mso-fareast-language:EN-CA;
mso-bidi-language:AR-SA'><span style='mso-element:field-end'></span></span><![endif]--> or by triggering an apneic event in infants using the Hering-Breuer reflex<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">2</span></span>.<br />
<br />
A recent doctoral thesis by Dr. Hannes Maes, under the supervision of Prof. Gerd Vandersteen at Vrije Universiteit Brussel (Free University of Brussels), titled, <i>Low Frequency Forced Oscillation Technique in Clinical Practice</i>, proposes an innovative solution to overcome confounding breathing frequencies, as well as a comprehensive review of the field<!--[if supportFields]><span style='font-size:10.0pt;
mso-bidi-font-size:11.0pt;font-family:"Segoe UI","sans-serif";mso-fareast-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:Calibri;
color:windowtext;mso-ansi-language:EN-CA;mso-fareast-language:EN-CA;mso-bidi-language:
AR-SA'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN
CSL_CITATION { "citationItems" : [ { "id" :
"ITEM-1", "itemData" : { "ISSN" :
"8750-7587", "PMID" : "2935519",
"abstract" : "Respiratory mechanical impedances were determined
during voluntary apnea in five healthy subjects, by means of 0.25- to 5-Hz
pseudo/random oscillations applied at the mouth. The total respiratory
impedance was partitioned into pulmonary (ZL) and chest wall components with
the esophageal balloon technique; corrections were made for the upper airway
shunt impedance and the compressibility of alveolar gas. Neglect of these shunt
effects did not qualitatively alter the frequency dependence of impedances but
led to underestimations in impedance, especially in the chest wall resistance
(Rw), which decreased by 20-30% at higher frequencies. The total resistance
(Rrs) was markedly frequency dependent, falling from 0.47 +/- 0.06 (SD) at 0.25
Hz to 0.17 +/- 0.01 at 1 Hz and 0.15 +/- 0.01 kPa X l-1 X s at 5 Hz. The
changes in Rrs were caused by the frequency dependence of Rw almost exclusively
between 0.25 and 2 Hz and in most part between 2 and 5 Hz. The effective total
respiratory (Crs,e) and pulmonary compliance were computed with corrections for
pulmonary inertance derived from three- and five-parameter model fittings of
ZL. Crs,e decreased from the static value (1.03 +/- 0.18 l X kPa-1) to a level
of approximately 0.35 l X kPa-1 at 2-3 Hz; this change was primarily caused by
the frequency-dependent behavior of chest wall compliance.",
"author" : [ { "dropping-particle" : "",
"family" : "Hantos", "given" : "Z",
"non-dropping-particle" : "", "parse-names" :
false, "suffix" : "" }, { "dropping-particle" :
"", "family" : "Dar\u00f3czy", "given"
: "B", "non-dropping-particle" : "",
"parse-names" : false, "suffix" : "" }, {
"dropping-particle" : "", "family" :
"Suki", "given" : "B", "non-dropping-particle"
: "", "parse-names" : false, "suffix" :
"" }, { "dropping-particle" : "",
"family" : "Galg\u00f3czy", "given" :
"G", "non-dropping-particle" : "",
"parse-names" : false, "suffix" : "" }, {
"dropping-particle" : "", "family" :
"Csendes", "given" : "T",
"non-dropping-particle" : "", "parse-names" :
false, "suffix" : "" } ], "container-title" :
"Journal of applied physiology (Bethesda, Md. : 1985)",
"id" : "ITEM-1", "issue" : "1",
"issued" : { "date-parts" : [ [ "1986",
"1" ] ] }, "page" : "123-32", "title" :
"Forced oscillatory impedance of the respiratory system at low
frequencies.", "type" : "article-journal",
"volume" : "60" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=81dc0d85-3730-3280-be8e-ebe61c4ce676"
] } ], "mendeley" : { "formattedCitation" :
"<sup>1</sup>", "plainTextFormattedCitation" :
"1", "previouslyFormattedCitation" :
"<sup>1</sup>" }, "properties" : {<span
style='mso-spacerun:yes'> </span>}, "schema" :
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"
}<span style='mso-element:field-separator'></span></span><![endif]--><span style="color: windowtext; font-family: "segoe ui" , sans-serif;"><sup><span style="font-size: xx-small;">3</span></sup></span><!--[if supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Segoe UI","sans-serif";
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:
Calibri;color:windowtext;mso-ansi-language:EN-CA;mso-fareast-language:EN-CA;
mso-bidi-language:AR-SA'><span style='mso-element:field-end'></span></span><![endif]-->.<br />
<br />
Dr. Maes presents a novel fan-based setup specifically designed for FOT measurements between 0-5 Hz in free-breathing subjects<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span><span style="font-family: "segoe ui" , sans-serif; font-size: xx-small;"> </span>Pressure signals (multi-sine wave) are superimposed on the patients normal tidal breathing by controlling two fans (one pushing and one pulling air). Compensatory signals are also applied to the fans to ensure a predefined power spectrum and to suppress the nonlinear influences of the equipment or the subject’s breathing, along with post-measurement modeling techniques.<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://1.bp.blogspot.com/-LzLZMY_F92I/WjpwRvnILPI/AAAAAAAABn4/M7rdc2hKsaQYIaUFPYH1DskcSPiPaoV8QCLcBGAs/s1600/schematic.png" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" data-original-height="264" data-original-width="809" height="130" src="https://1.bp.blogspot.com/-LzLZMY_F92I/WjpwRvnILPI/AAAAAAAABn4/M7rdc2hKsaQYIaUFPYH1DskcSPiPaoV8QCLcBGAs/s400/schematic.png" width="400" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Schematic of fan-based FOT measurement device for free-breathing subjects</td></tr>
</tbody></table>
<br />
<br /></div>
<div style="text-align: justify;">
Results from a clinical trial on 60 subjects, that included healthy individuals as well as asthmatic and COPD patients, are also presented and, in the end, Dr. Maes offers a new framework for the time-varying behavior of the respiratory system during spontaneous breathing.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
We congratulate Dr. Maes on this achievement and very interesting approach. This elegant work contributes towards the advances required to ultimately enable routine provision of the low-frequency FOT in patient populations and for clinicians to benefit from its diagnostic capacity.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
For more information on the work of Dr. Maes and access to the full manuscript, please click <a href="http://vubirelec.be/people/hannes-maes" target="_blank"><b>here</b></a>.</div>
<span style="font-size: x-small;"><br /></span>
<br />
<div style="text-align: justify;">
<span style="font-size: x-small;">1.<span style="white-space: pre;"> </span>Hantos, Z., Daróczy, B., Suki, B., Galgóczy, G. & Csendes, T. Forced oscillatory impedance of the respiratory system at low frequencies. <i>J. Appl. Physiol.</i> <b>60</b>, 123–32 (1986).</span></div>
<div style="text-align: justify;">
<span style="font-size: x-small;">2.<span style="white-space: pre;"> </span>Hall, G. L., Hantos, Z., Wildhaber, J. H. & Sly, P. D. Contribution of nasal pathways to low frequency respiratory impedance in infants. <i>Thorax</i> <b>57</b>, 396–9 (2002).</span></div>
<div style="text-align: justify;">
<span style="font-size: x-small;">3.<span style="white-space: pre;"> </span>Maes, H. Low Frequency Forced Oscillation Technique in Clinical Practice. (Vrije Universiteit Brussel, Belgium, 2017).</span></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div style="text-align: justify;">
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-84003351765055946282018-03-05T10:36:00.001-05:002018-03-05T10:36:06.955-05:00SCIREQ INTRODUCES DRY POWDER DELIVERY AT SOT / TOXEXPO 2018<div style="text-align: justify;">
Many novel inhaled compounds and drugs require dry powder delivery and preclinical testing to assess efficacy and safety. The <a href="http://www.scireq.com/inexpose" target="_blank">inExpose</a> is an inhalation exposure system that provides a small-scale, configurable exposure for mice and rats studies.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Our recent addition of <b>dry powder delivery</b> expands the range of exposure environments beyond cigarette smoke, electronic cigarette vape, aerosols and gases.</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-kg77NGSumV0/Wp1fUO67RvI/AAAAAAAABqA/6wlrJ_jPJo8T9oXT7xy-Dt_J_6Y8eyN7QCLcBGAs/s1600/IX%2BDry%2BPowder.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://2.bp.blogspot.com/-kg77NGSumV0/Wp1fUO67RvI/AAAAAAAABqA/6wlrJ_jPJo8T9oXT7xy-Dt_J_6Y8eyN7QCLcBGAs/s400/IX%2BDry%2BPowder.JPG" width="400" /></a></div>
<br />
<b>The dry powder integration with the inExpose features:</b><br />
» Up to 4 towers or chamber to be exposed simultaneously<br />
» Identical or varying levels of exposure per tower or chamber<br />
» Existing automation and control<br />
» Small- scale exposure, minimizing compound use<br />
<br />
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Will you be attending the <b>Society of Toxicology</b> meeting in San Antonio next week? If so, I would like to invite you to come by booth<b> #1545</b> to see our solutions for your preclinical respiratory research. We will be presenting a range of precise preclinical physiology solutions for safety pharmacology and toxicology studies, including:</div>
<br />
» Automated, small-scale inhalation exposure studies featuring<br />
cigarettes, e-cigarettes, dry powders and aerosols<br />
» Non-invasive tracking of ventilatory patterns and controlled gas exposure <br />
with whole body plethysmography<br />
» Continuous monitoring of physiological parameters with implantable and<br />
jacketed telemetry<br />
<br />
<b>Exhibit hours - </b><b>Booth 1545</b><br />
Monday March 12 <span style="white-space: pre;"> </span>9:15am to 4:30pm<br />
Tuesday March 13 <span style="white-space: pre;"> </span>9:15am to 4:30pm<br />
Wednesday March 14 <span style="white-space: pre;"> </span> 9:15am to 4:30pm<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-UGffzf6VCsg/Wp1fFhr8GlI/AAAAAAAABp8/jMc9NTDNhQgLFqLRZobDNTbuEQrZab2ewCEwYBhgL/s1600/SOT%2B%2Bfloorplan%2B1545.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1080" data-original-width="1600" height="267" src="https://1.bp.blogspot.com/-UGffzf6VCsg/Wp1fFhr8GlI/AAAAAAAABp8/jMc9NTDNhQgLFqLRZobDNTbuEQrZab2ewCEwYBhgL/s400/SOT%2B%2Bfloorplan%2B1545.jpg" width="400" /></a></div>
<div class="separator" style="clear: both; text-align: left;">
<a href="mailto:events@scireq.com" target="_blank">Click here</a> to set-up a meeting to learn more about our solutions for your safety pharmacology and toxicology studies. </div>
<br />
If you are not planning to attend the conference but would like to receive additional information about our respiratory equipment, please <a href="http://www.scireq.com/company/contact-us" target="_blank">contact</a> our team of application specialists.<br />
<br />
Looking forward to seeing you in San Antonio!<br />
<br />SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-61102294819835741092018-02-26T08:30:00.002-05:002018-02-26T08:30:37.327-05:00flexiVent User Group Meeting - April 26, 218 in San Diego<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-BTWZ7QMI2GQ/WpQKsMthYnI/AAAAAAAABps/KbpPbEAApOADHBcCIi-Zi6j137RW5SzewCLcBGAs/s1600/SAVE%2BTHE%2BDATE%2B-%2BUGM%2BSan%2BDiego%2B2018%2BLOGO.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="270" data-original-width="1583" height="66" src="https://1.bp.blogspot.com/-BTWZ7QMI2GQ/WpQKsMthYnI/AAAAAAAABps/KbpPbEAApOADHBcCIi-Zi6j137RW5SzewCLcBGAs/s400/SAVE%2BTHE%2BDATE%2B-%2BUGM%2BSan%2BDiego%2B2018%2BLOGO.jpg" width="400" /></a></div>
<h4 style="text-align: center;">
Join us for a day of scientific presentations and discussions to learn more about the flexiVent’s capabilities & applications and share your feedback with other users. </h4>
<div>
<br /></div>
<b>WHEN?</b> Thursday April 26, 2018<br />
Following the Experimental Biology Conference 2018<br />
<br />
<b>WHERE?</b> San Diego, California (<a href="http://www3.hilton.com/en/hotels/california/hilton-san-diego-bayfront-SANCCHH/index.html" target="_blank">Hilton San Diego Bayfront</a>)<br />
<br />
<b>AGENDA:</b> » Presentation & Demo by our flexiVent Experts<br />
» Case Studies & Interactive Session<br />
» User Presentation: Learn how others use the flexiVent<br />
» Recent Developments and a chance to ask your questions<br />
<br />
Final Agenda and Details coming soon! Space is limited, please <a href="http://www.scireq.com/flexivent-user-group-meeting-san-diego-2018-registration" target="_blank"><b>CLICK HERE</b></a> to register and be part of this event.<br />
<br />
If you are interested in presenting your pulmonary research work during this user group, do not hesitate to contact us as soon as possible, to include your presentation in the agenda.<br />
<br />
Please note that this user group meeting will be free of charge.<br />
<br />
If you have any questions, do not hesitate to contact us at <a href="mailto:events@scireq.com">events@scireq.com</a> or toll-free at 1-877-572-4737.<br />
<br />
We look forward to seeing you in San Diego!<br />
<br />
Best regards,<br />
Your SCIREQ Team<br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-22769024261719757672018-02-21T09:00:00.000-05:002018-02-21T09:21:58.907-05:00SCIREQ at AAAAI & WAO Joint Congress in OrlandoWill we see you at the American Academy of Allergy Asthma & Immunology (AAAAI) conference in Orlando, next week? This congress is a wonderful opportunity to convene with other world-class researchers to discuss the latest discoveries in asthma and inflammatory diseases.<br />
<br />
Mouse models have been and continue to be of invaluable importance in asthma research, for the elucidation of key disease pathways as well as in the assessment of potential therapies as <a href="http://blog.scireq.com/2017/02/asthma-from-mouse-to-man.html" target="_blank">highlighted in recent articles</a>.<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://3.bp.blogspot.com/-K-4C6NkFYbM/WmowgJgbfdI/AAAAAAAABpM/WLevvuWlZwg8Kosiyud5ZAjd8CHA3vCewCLcBGAs/s1600/SCIREQgraph-Asthma-mouse-to-man.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="896" data-original-width="1600" height="179" src="https://3.bp.blogspot.com/-K-4C6NkFYbM/WmowgJgbfdI/AAAAAAAABpM/WLevvuWlZwg8Kosiyud5ZAjd8CHA3vCewCLcBGAs/s320/SCIREQgraph-Asthma-mouse-to-man.jpg" width="320" /></a></div>
<br />
SCIREQ enables scientists to measure detailed lung function outcomes utilizing the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a>, which has become the gold-standard for <i>in vivo</i> respiratory research.<br />
<br />
Join us at <b>booth 229</b> to learn more. <br />
<b><u><br /></u></b>
<b><u>Exhibit Hours</u></b><br />
Saturday, March 3: 9:45am – 3:15pm<br />
Sunday, March 4:<span style="white-space: pre;"> </span> 9:45am – 3:15pm<br />
Monday, March 5:<span style="white-space: pre;"> </span> 9:45am – 2pm<br />
<br />
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-8Qg2JF_z5PU/WmotaV2bwhI/AAAAAAAABpA/nLtqg8husdIVvjWw8XWrwlDAlQcDRm1ygCLcBGAs/s1600/AAAAI-%2526-WAO-2108-Floorplan-Booth-229.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1274" data-original-width="1600" height="317" src="https://1.bp.blogspot.com/-8Qg2JF_z5PU/WmotaV2bwhI/AAAAAAAABpA/nLtqg8husdIVvjWw8XWrwlDAlQcDRm1ygCLcBGAs/s400/AAAAI-%2526-WAO-2108-Floorplan-Booth-229.jpg" width="400" /></a></div>
<br />
<br />
» <a href="mailto:events@scireq.com?subject=%20Meet%20with%20SCIREQ%20during%20AAAAI" target="_blank">Click here</a> to set-up a meeting with our specialists during or after the symposium.<br />
» <a href="http://annualmeeting.aaaai.org/" target="_blank">Click here</a> to view the AAAAI & WAO Joint Congress details.<br />
<br />
If you are not planning to attend the conference but would like to receive additional information about our respiratory equipment, please <a href="http://www.scireq.com/company/contact-us" target="_blank">contact</a> our team of application specialists.<br />
<br />
<br />
<br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-73156253912449435492018-02-19T08:37:00.000-05:002018-02-19T08:37:41.207-05:00Upgrade to flexiWare 8.0<div class="MsoNormal">
We are happy to announce the release of flexiWare 8.0! This latest version is unified software for both the flexiVent and inExpose systems and flexiWare 8.0 includes features such as:<br />
<br /></div>
<div class="MsoNormal">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-RQwJXBaZ_Mo/WnDbghXleFI/AAAAAAAABpg/GDOUFo780i4lmZ48Gp6z4aAeQN2uAsQWQCLcBGAs/s1600/fw8.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="330" data-original-width="600" height="220" src="https://4.bp.blogspot.com/-RQwJXBaZ_Mo/WnDbghXleFI/AAAAAAAABpg/GDOUFo780i4lmZ48Gp6z4aAeQN2uAsQWQCLcBGAs/s400/fw8.png" width="400" /></a></div>
<br /></div>
<h3>
FLEXIVENT</h3>
<div class="MsoNormal">
</div>
<ul>
<li>Official release of the <a href="http://www.scireq.com/flexivent/techniques-and-measurements#lung_volumes" target="_blank">Lung Volumes</a> maneuver along with its associated tasks and outcomes!</li>
<li>Diagnostic & power-on Self-Test available, allowing for greater confidence in the system and easier troubleshooting.</li>
<li>Significantly reduced time to load and view data in review mode (retroactively available for previously collected data as well).</li>
<li>Pop-up now appears on screen to notify users of excluded datasets as they occur to allow for immediate action.</li>
<li>Ability to copy subjects when creating new subjects or studies.</li>
</ul>
<br />
<h3>
INEXPOSE</h3>
<div class="MsoNormal">
</div>
<ul>
<li>System leak test available with easy to follow software wizard to ensure the system is leak free prior to beginning an experimentation session.</li>
<li>Ability to reinitialize and modify CSR setting anytime during an experimentation session.</li>
<li>Significantly improved and integrated profile editor, including the ability to view pump and nebulizer trigger signals in real-time.</li>
<li>Scripting capabilities added for complex protocols as well as for improved standardization.</li>
<li>Ability to create export scenarios for easier data export.</li>
</ul>
<br />
<div>
<div>
<h3>
Ready to upgrade?</h3>
</div>
<div>
Contact us to find out if you are eligible for a free upgrade and how to have flexiWare 8.0 running in your lab!<br />
<br />
Phone: 1.514.286.1429<br />
Toll Free: 1.877.572.4737<br />
Email: <a href="mailto:sales@scireq.com" target="_blank">sales@scireq.com</a><br />
<br /></div>
</div>
<div class="MsoListParagraphCxSpLast" style="mso-list: l0 level1 lfo1; text-indent: -18.0pt;">
<o:p></o:p></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-18504235279761797932018-01-22T10:08:00.000-05:002018-01-22T10:08:35.126-05:00Refined Study Design with Spirometry<div style="text-align: justify;">
Spirometry is a widely known clinical pulmonary test measuring volumes and flows expired by patients that is used to confirm a diagnostic of respiratory disease or follow treatment. SCIREQ’s flexiVent’s offers an analogous test for preclinical research with its <a href="http://www.scireq.com/flexivent/configurations-extensions#fev" target="_blank">Negative Pressure Forced Expiration (NPFE) extension</a>. By exposing the subject’s airway opening to a negative pressure to rapidly draw out air from the lungs, the system can generate flow-volume loops or volume-time plots, from which the flexiWare software can then extract clinically relevant volume and flow parameters (e.g. <a href="http://www.scireq.com/flexivent/techniques-and-measurements#fev_measurement" target="_blank">FEVx, FEFx, FVC, PEF</a>).</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
A recent publication by Devos et al.<sup><span style="font-family: "segoe ui" , sans-serif;"><span style="font-size: xx-small;">1</span></span></sup> characterized forced expiration measurements in some well-established mouse models of lung diseases, which specific phenotypes were confirmed by a concomitant respiratory mechanics assessment. The researchers observed that disease-induced changes in forced expiration-related charts and parameters were generally similar to what was observed in the clinic. For example, when compared to a control group of healthy mice.</div>
<br />
<ul>
<li style="text-align: justify;">Mice with fibrosis exhibited a typical restrictive profile, with a reduced PEF & FVC and a normal FEV<span style="font-size: xx-small;">0.1</span>/FVC ratio. </li>
<li style="text-align: justify;">Mice with emphysema displayed a decrease in PEF characteristic of an obstructive phenotype.</li>
<li style="text-align: justify;">Mice presenting an acute lung injury had significantly reduced PEF.</li>
<li style="text-align: justify;">Mice with features of asthma showed a decrease in FEV<span style="font-size: xx-small;">0.1</span> following methacholine challenges.</li>
</ul>
<br />
<div style="text-align: justify;">
SCIREQ’s <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a> is the first platform that allows forced expiratory manoeuvres to be performed side-by-side with respiratory mechanics, pressure-volume loops, or lung volume measurements in mice and rats. This unique feature enables a refined study design with outcomes susceptible to translate between preclinical research and clinical settings. </div>
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-2P6aJMyYaEk/WjAe1x_P8MI/AAAAAAAABno/zdMKr_WyUYsfVa_9F9rtAg4ulVl7W_aMQCLcBGAs/s1600/FX%2BFEV%2Bconfiguration_computer.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="710" data-original-width="1600" height="176" src="https://1.bp.blogspot.com/-2P6aJMyYaEk/WjAe1x_P8MI/AAAAAAAABno/zdMKr_WyUYsfVa_9F9rtAg4ulVl7W_aMQCLcBGAs/s400/FX%2BFEV%2Bconfiguration_computer.png" width="400" /></a></div>
<br />
<br />
<b>Read more</b><br />
<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span>Devos, FC et al. 2017. Forced expiration measurements in mouse models of obstructive and restrictive lung diseases. Respiratory Research 18: 123.<br />
<a href="https://www.blogger.com/goog_207559946"><br /></a>
<a href="http://blog.scireq.com/2017/11/comprehensive-lung-function-assessments_27.html">http://blog.scireq.com/2017/11/comprehensive-lung-function-assessments_27.html</a><br />
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-82504257806545184972018-01-22T08:55:00.000-05:002018-02-05T08:56:35.144-05:00Leaving Nothing Out<div style="text-align: justify;">
The functional residual capacity (FRC) plays an important role in maintaining optimal ventilation. FRC is a subdivision of the total lung capacity (TLC) and represents the volume of air left in the lungs at the end of an expiration. It is involved in keeping the small airways open for an efficient gas transfer between the air and the blood. Variations in that volume can be seen under several physiological or pathophysiological conditions and can be associated with clinical symptoms like dyspnea. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
FRC is a clinically important parameter which is determined, along with other lung volumes/capacities, when performing a full lung function assessment. It is inversely related to airway resistance, such that a reduction in FRC will increase the level of opposition to airflow. At the preclinical level, while measurements of airway resistance are routinely performed in many research laboratories, the determination of FRC is rarely reported as it can prove to be technically challenging, especially in subjects as small as mice. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
It is possible to obtain FRC from a full-range pressure-volume (PV) curve. This was done until now in mice by determining the volume at a conventionally or arbitrarily defined equilibrium pressure (e.g. 0 cmH20), since FRC represents the volume at rest. In a <a href="http://www.physiology.org/doi/abs/10.1152/japplphysiol.00856.2016" target="_blank">recent report</a><sup><span style="font-family: "segoe ui" , sans-serif;"><span style="font-size: xx-small;">1</span></span></sup>, FRC was estimated by a novel approach in rodents, following the automation of the full-range PV curve technique with SCIREQ’s <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a> system. It was estimated by volume subtraction and took advantage of the access to varied, precisely controlled, automated maneuvers within a single device. In comparison to the previously established methodology, this novel approach demonstrated a more accurate estimation of FRC, particularly in diseased subjects.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The estimation of FRC by volume subtraction can be performed in rats and mice along with the determination of other lung volumes/capacities, measurements of respiratory mechanics, or partial PV curves. The authors showed that the FRC estimate more than tripled in a mouse model of emphysema, representing the most important change in a panel of lung volumes/capacities. Including measurements of FRC and other lung volumes/capacities in the characterization of respiratory models or novel therapeutic strategies can contribute to generate comprehensive and robust functional assessments. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
No model fully recapitulates human respiratory diseases. Let’s reconsider the endpoints typically reported so that nothing that matters gets ignored.</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-5pmzzgMhyio/WjAD1R5h9wI/AAAAAAAABnY/5-P78wCGSvg2drZSi6AiuTQ2IQbekOQfACLcBGAs/s1600/lung%2Bvolumes_captions.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="323" data-original-width="545" height="189" src="https://4.bp.blogspot.com/-5pmzzgMhyio/WjAD1R5h9wI/AAAAAAAABnY/5-P78wCGSvg2drZSi6AiuTQ2IQbekOQfACLcBGAs/s320/lung%2Bvolumes_captions.png" width="320" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
<b>Read more</b></div>
<div style="text-align: justify;">
<span style="font-family: "segoe ui" , sans-serif; font-size: 10pt; vertical-align: super;">1</span>Robichaud, A et al. 2017. Automated full-range pressure-volume curves in mice and rats. Journal of Applied Physiology 123: 746-756.</div>
<div style="text-align: justify;">
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-19354012575032738692018-01-08T10:43:00.000-05:002018-01-11T15:19:13.565-05:00Empower yourself<div style="text-align: justify;">
Attending a training such as the Phenotyping Mice Models of Human Lung Disease organized by the <a href="https://www.jax.org/" target="_blank">Jackson Laboratory</a> is a great way to advance skillsets or simply get started in the field of respiratory research. It represents a wonderful opportunity for researchers of all stages to learn and network in a structured yet informal environment. The uniqueness of the event lies in the roundness of the approach, which combines theoretical sessions and practical experience in all topics.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
SCIREQ has been a partner in this event for years now and has contributed with providing hands-on experience to participants with lung function measurements using the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a> alongside authorities in the field. Practical exercises are designed to demonstrate a response to a particular intervention, highlight unique measurements (including partitioning the lungs between airway and tissue effects), and analyze outcomes with respect to their physiological implications.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>JAX Experiments</b></div>
<div style="text-align: justify;">
As an example, participants were guided during the last workshop to utilize pressure-volume loops to confirm the effects of an intervention with implications on lung surfactant and atelectasis. </div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://2.bp.blogspot.com/-Mgb_ad1EQLo/Wk04ZWJM1aI/AAAAAAAABoI/4l_94uLntiIdV9HQ3_B-2E1L8FzBNI0swCLcBGAs/s1600/pressure%2Bvolume%2Bloops%2Bfrom%2Ba%2Bsubject%2Bbefore.png" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" data-original-height="600" data-original-width="1039" height="230" src="https://2.bp.blogspot.com/-Mgb_ad1EQLo/Wk04ZWJM1aI/AAAAAAAABoI/4l_94uLntiIdV9HQ3_B-2E1L8FzBNI0swCLcBGAs/s400/pressure%2Bvolume%2Bloops%2Bfrom%2Ba%2Bsubject%2Bbefore.png" width="400" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Figure 1: Pressure-volume loops from a subject before (left) and after (right) a lung lavage. The red line represents the Salazar-Knowles equation fit to the deflation limb of the pressure-volume curve.</td></tr>
</tbody></table>
<div style="text-align: justify;">
They were also invited to examine the effect of increasing the positive end expiratory pressure (PEEP) during ventilation and lung function measurements while exploring the impact on detailed respiratory mechanics parameters before and after the intervention.<br />
<br /></div>
<div style="text-align: justify;">
Airway responsiveness to a specific bronchoconstrictor agent before and after a therapeutic treatment or an assessment of various <a href="http://www.scireq.com/flexivent/techniques-and-measurements#lung_volumes" target="_blank">lung volumes</a> are also typically part of the repertoire of techniques taught. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://3.bp.blogspot.com/-DEowehgK6Wo/Wk046MTrR8I/AAAAAAAABoQ/AnrK9PdZtoQRrXk9HDqeDSz1HXUUlxuGACLcBGAs/s1600/figure%2B2.png" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" data-original-height="877" data-original-width="1253" height="277" src="https://3.bp.blogspot.com/-DEowehgK6Wo/Wk046MTrR8I/AAAAAAAABoQ/AnrK9PdZtoQRrXk9HDqeDSz1HXUUlxuGACLcBGAs/s400/figure%2B2.png" width="400" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Figure 2: Single (left) and broadband (right) forced oscillation outcomes prior to and following increasing doses of nebulised methacholine in presence or absence of a bronchodilator treatment.</td></tr>
</tbody></table>
<div style="text-align: justify;">
<div>
<b><br /></b></div>
<div>
<b>Looking forward</b></div>
<div>
The event runs every second year in Bar Harbor, Maine, and accepts a limited number of participants. Plan ahead to take part in the workshop, which we highly recommend to both senior researchers and students alike. </div>
<div>
<br /></div>
</div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-11479735511962902222017-12-13T12:56:00.002-05:002017-12-13T12:56:52.941-05:00Happy Holidays from all of us at SCIREQ!<h2 style="clear: both; text-align: center;">
</h2>
<h2 style="text-align: center;">
<div class="MsoNormal" style="margin-left: 35.4pt; text-align: center;">
<div style="text-align: center;">
<br /></div>
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-ksfmlyGNcYQ/Wil3LjYD3_I/AAAAAAAABm0/_sdLLmbcdJIO-IbKQU23eQgO5D1CRMQcACLcBGAs/s1600/Greeting%2Bcard%2B2017-scireq%2B%25282%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1434" height="400" src="https://4.bp.blogspot.com/-ksfmlyGNcYQ/Wil3LjYD3_I/AAAAAAAABm0/_sdLLmbcdJIO-IbKQU23eQgO5D1CRMQcACLcBGAs/s400/Greeting%2Bcard%2B2017-scireq%2B%25282%2529.jpg" width="356" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: center;">
<span style="color: #006bb2; font-family: "segoe ui" , sans-serif; text-align: left; text-indent: 35.4pt;"><span style="font-size: large;"><br /></span></span></div>
<div style="text-align: center;">
<br /></div>
<div style="text-align: center;">
<span style="color: #006bb2; font-family: "segoe ui" , sans-serif; text-align: left; text-indent: 35.4pt;"><span style="font-size: large;">Best Wishes for Health, Happiness and Reproducible Research in
2018!</span></span></div>
<div style="text-align: center; text-indent: 47.2px;">
<br /></div>
</h2>
<div style="text-align: center;">
<div>
<br />
<br /></div>
<div>
<br /></div>
<h3 style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; margin: 0px; position: relative; text-align: start; text-transform: uppercase;">
HOLIDAY OFFICE HOURS</h3>
<div style="text-align: start;">
<br />
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px;">
<b style="font-size: 14.85px;">SCIREQ Scientific Respiratory Equipment Inc.</b><span style="font-size: 14.85px;"> (Montreal, QC, Canada)</span></div>
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px;">
Closed from Monday, December 25th to Monday, January 1st.</div>
</div>
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px; text-align: start;">
<b><br /></b>
<b>emka TECHNOLOGIES S.A.S.</b> (Paris, France)<br />
Closed from <span style="font-size: 14.85px;">Monday, December 25th to Monday, January 1st.</span></div>
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px; text-align: start;">
<br /></div>
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px; text-align: start;">
<b>emka TECHNOLOGIES Inc.</b> (Falls Church, VA, U.S.A.)<br />
Closed on <span style="font-size: 14.85px;">Monday, December 25th and Monday, January 1st</span> only. Open all other days.</div>
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px; text-align: start;">
<br /></div>
<div style="background-color: white; color: #505050; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 14.85px; text-align: start;">
<br />
<br />
<br /></div>
</div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-30418005493450595872017-12-04T11:48:00.000-05:002017-12-04T11:48:37.427-05:00Why we need a mouse – Little mice bring big hope to the rare disease community<div class="MsoNormal">
<a href="https://1.bp.blogspot.com/-B0y-bAJKLtg/WhR7AI48STI/AAAAAAAABl8/_dZkWoY92D89VzMBk-gWgZb9kM2RlNmiQCLcBGAs/s1600/animal%2Bicon%2Bmouse%2Bblue.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="98" data-original-width="141" height="138" src="https://1.bp.blogspot.com/-B0y-bAJKLtg/WhR7AI48STI/AAAAAAAABl8/_dZkWoY92D89VzMBk-gWgZb9kM2RlNmiQCLcBGAs/s200/animal%2Bicon%2Bmouse%2Bblue.png" width="200" /></a>Animal models are important research tools for all human
diseases, but they are especially crucial when it comes to understanding and figuring
out treatments of rare diseases. Mouse models are the key to these researchers.
Alternatives such as test tubes and computer simulations are not advanced enough
to model all the interactions that go on inside a living creature. Researchers
need to run experiments in whole organisms to unravel biological mechanisms and
test therapies effectively. Without mice, much of today’s genetic research and
medical progress would stutter to a halt.<sup><span style="font-size: xx-small;">1</span></sup></div>
<div class="MsoNormal">
<o:p></o:p></div>
<div class="MsoNormal">
<br />
<div class="MsoNormal">
While working with <i>in vivo</i> models of pulmonary diseases can
be challenging, even intimidating, SCIREQ has enabled scientists of all
backgrounds to measure detailed lung function outcomes for almost 20 years with
the <a href="http://www.scireq.com/flexiVent" target="_blank">flexiVent</a>.<o:p></o:p></div>
<br />
<br /></div>
<div class="MsoNormal">
<b>References<o:p></o:p></b></div>
<div class="MsoNormal">
<sup><span style="font-size: xx-small;">1</span></sup> Niewijk, Grace (2017, October 4). <i style="font-size: medium;">Why we need a mouse</i>. Retrieved from <a href="https://medium.com/s/rare-and-orphan/why-we-need-a-mouse-7b7f5799569d" style="font-size: medium;">https://medium.com/s/rare-and-orphan/why-we-need-a-mouse-7b7f5799569d</a>
<o:p></o:p></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b>Read the 4 part article</b> “Rare and Orphan – How we research,
treat and live with rare diseases” here:<o:p></o:p></div>
<div class="MsoNormal">
<a href="https://medium.com/s/rare-and-orphan">https://medium.com/s/rare-and-orphan</a><o:p></o:p></div>
<div class="MsoNormal">
<br /></div>
<br />
<div class="MsoNormal">
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-64055374254846774322017-11-27T12:25:00.000-05:002017-12-12T13:49:10.962-05:00COMPREHENSIVE LUNG FUNCTION ASSESSMENTS <div style="text-align: justify;">
In patients suspected of a respiratory disease, the confirmation of a clinical diagnosis is often established following functional tests that can include spirometry, specific lung volumes/capacities, or both. As in humans, the characterization of a disease model or novel therapeutic approach at the basic science or pre-clinical level could also potentially necessitate functional measurements of various nature to convincingly confirm a respiratory phenotype. </div>
<div style="text-align: justify;">
<br /></div>
<table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://3.bp.blogspot.com/-xeUv8zC1zVw/WhSDoxAl-ZI/AAAAAAAABmQ/NV0T1EODr-EGezOgzJAeDmyuMR0y6kr0QCLcBGAs/s1600/forced-oscillation-tech.jpg" imageanchor="1" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" data-original-height="580" data-original-width="580" height="200" src="https://3.bp.blogspot.com/-xeUv8zC1zVw/WhSDoxAl-ZI/AAAAAAAABmQ/NV0T1EODr-EGezOgzJAeDmyuMR0y6kr0QCLcBGAs/s200/forced-oscillation-tech.jpg" width="200" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><div style="text-align: left;">
<span style="font-size: 12.8px;"><b>Did you know?</b></span></div>
<div style="text-align: left;">
<span style="font-size: 12.8px;">The flexiVent was the first commercial device to</span></div>
<div style="text-align: left;">
<span style="font-size: 12.8px;">measure respiratory mechanics using the forced</span></div>
<div style="text-align: left;">
<span style="font-size: 12.8px;">oscillation technique in animals.</span></div>
</td></tr>
</tbody></table>
<div style="text-align: justify;">
Pre-clinical lung function tests frequently involve an assessment by <a href="http://www.scireq.com/flexivent/techniques-and-measurements#fot" target="_blank"><b>forced oscillation</b></a>. This provides precise and detailed measurements that are undisputed to characterize the mechanical properties of the respiratory system. In some cases, it could be desirable to complement this evaluation with other disease sensitive outcomes or conditions to gain further insight either on the underlying mechanisms or the potential of the tested disease model or therapeutic approach at translating into something of clinical relevance. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
As shown in some recent publications<sup><span style="font-family: "segoe ui" , sans-serif;"><span style="font-size: xx-small;">1, 2</span></span></sup>, combined measurements can seamlessly be done within the same subjects and experiment using a <a href="http://www.scireq.com/flexivent" target="_blank"><b>single device - the flexiVent</b></a>. In these specific studies, forced expiration and lung volume measurements were performed in combination with a respiratory mechanics assessment to further characterize a number of disease models at baseline and/or following bronchoprovocation<span style="font-family: "Segoe UI", sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span> or to broaden the evaluation using various lung volumes and capacities<sup><span style="font-family: "segoe ui" , sans-serif;"><span style="font-size: xx-small;">2</span></span></sup>. </div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-JUBBmqsDD3w/WhSDW9tI1FI/AAAAAAAABmM/PWmUiAUI4bI56vu6n1SV_09MsyeD3uB2wCLcBGAs/s1600/FX%2Bw%2Bcomputer_animals%2B-%2BCopy.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="739" data-original-width="1050" height="224" src="https://2.bp.blogspot.com/-JUBBmqsDD3w/WhSDW9tI1FI/AAAAAAAABmM/PWmUiAUI4bI56vu6n1SV_09MsyeD3uB2wCLcBGAs/s320/FX%2Bw%2Bcomputer_animals%2B-%2BCopy.png" width="320" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Lung function measurement is one of our favorite discussion topics. <a href="mailto:info@scireq.com" target="_blank"><b>Contact us</b></a> for more information.</div>
<br />
<br />
<div>
<div>
<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span><span style="font-size: x-small;">Devos, FC et al. 2017. Forced expiration measurements in mouse models of obstructive and restrictive lung diseases. Respiratory Research 18: 123.</span></div>
<div>
<span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">2</span></span><span style="font-size: x-small;">Robichaud, A et al. 2017. Automated full-range pressure-volume curves in mice and rats. Journal of Applied Physiology 123: 746-756.</span></div>
</div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-78309010309983961902017-11-01T09:34:00.000-04:002017-11-01T09:34:10.668-04:00Alpha-1 Antitrypsin (AAT) Deficiency <div style="text-align: justify;">
Alpha-1 antitrypsin (AAT) deficiency is an inherited disorder, most prevalent in populations of European ancestry, and is underdiagnosed. It results from mutations in the <i>SERPINA1</i> gene, leading to either a reduced level or function of the AAT protein. AAT deficiency results a variety of health issues, particularly predisposition to the development of liver and lung disease<sup><span style="color: windowtext; font-family: "Segoe UI", sans-serif;"><span style="font-size: xx-small;">1</span></span></sup>. When exacerbated by smoking, this results in damage to the alveoli and ultimately emphysema with many of the features of COPD<span style="color: windowtext; font-family: "Segoe UI", sans-serif; vertical-align: super;"><span style="font-size: xx-small;">1</span></span>.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The recently published <i><a href="https://link.springer.com/protocol/10.1007/978-1-4939-7163-3_8" target="_blank">Alpha-1 Antitrypsin deficiency</a></i>, in the Methods in Molecular Biology series (Springer Protocols) provides a comprehensive background to this disease and state-of-the-art methods<sup><span style="color: windowtext; font-family: "Segoe UI", sans-serif;"><span style="font-size: xx-small;">2</span></span></sup>, including a chapter outlining the use of the forced oscillation technique to assess lung structure and function relationships, with focus on the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent</a><sup><span style="color: windowtext; font-family: "Segoe UI", sans-serif;"><span style="font-size: xx-small;">3</span></span></sup>.</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://3.bp.blogspot.com/-y8NJ-JdYGY8/WfnL78TaCGI/AAAAAAAABls/pNRQXLLx484yTjnDIY3o_zEuQ4dUbG4ZQCLcBGAs/s1600/978-1-4939-7163-3.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="217" data-original-width="153" src="https://3.bp.blogspot.com/-y8NJ-JdYGY8/WfnL78TaCGI/AAAAAAAABls/pNRQXLLx484yTjnDIY3o_zEuQ4dUbG4ZQCLcBGAs/s1600/978-1-4939-7163-3.jpg" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Recent years have seen exciting developments in both the development of animal models for AAT deficiency research and proof of principle studies for treatment approaches. Using adeno-associated virus 2/8 to direct gene delivery specifically to mouse lung Payne et al were able to demonstrate not only elevated serum AAT but also protection against elastase-induced augmentation of compliance – measured using the <a href="http://www.scireq.com/flexivent/techniques-and-measurements#fot" target="_blank">forced-oscillation technique (FOT) on the flexiVent</a><sup><span style="color: windowtext; font-family: "Segoe UI", sans-serif;"><span style="font-size: xx-small;">4</span></span></sup>.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Cox et al. performed pressure-volume loops and utilised the FOT with the flexiVent to confirm the increased compliance, with LPS challenge, of a newly developed mouse model of AAT deficiency. Generated using CRISPR/Cas9 genome editing, the model demonstrates many of the hallmark features of the human disease<sup><span style="color: windowtext; font-family: "Segoe UI", sans-serif;"><span style="font-size: xx-small;">5</span></span></sup>. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
With the development of animal models which more closely resemble human disease, progress in the search for effective treatments will be greatly accelerated. SCIREQ looks forward to helping provide tools for this research.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<span style="font-size: xx-small;"><br /></span></div>
<div style="text-align: justify;">
<div>
<span style="font-size: xx-small;">1-<span style="white-space: pre;"> </span>Stoller, James K., and Loutfi S. Aboussouan. “A Review of α1-Antitrypsin Deficiency.”<i>American Journal of Respiratory and Critical Care Medicine</i>, vol. 185, no. 3, 2012, pp. 246–259., doi:10.1164/rccm.201108-1428ci.</span></div>
<div>
<span style="font-size: xx-small;">2-<span style="white-space: pre;"> </span>Borel, F., & Mueller, C. (Eds.). (2017).<i> Alpha-1 Antitrypsin Deficiency</i> (Vol. 1639). New York, NY: Springer New York. https://doi.org/10.1007/978-1-4939-7163-3</span></div>
<div>
<span style="font-size: xx-small;">3-<span style="white-space: pre;"> </span>Parameswaran H., Suki B. (2017) Assessing Structure–Function Relations in Mice Using the Forced Oscillation Technique and Quantitative Histology. In: Borel F., Mueller C. (eds) Alpha-1 Antitrypsin Deficiency. Methods in Molecular Biology, vol 1639. Humana Press, New York, NY</span></div>
<div>
<span style="font-size: xx-small;">4-<span style="white-space: pre;"> </span>Payne, J., Takahashi, A., Lonza, G., Balazs, A., Suki, B., Kotton, D. and Wilson, A., “Lung-Directed Gene Delivery Of Alpha-1 Antitrypsin Using Intratracheal Adeno-Associated Virus 2/8 In A Mouse Model Of Emphysema”, Poster presented at: ATS 2014, D38 Update in alpha one deficiency, May 21st, 2014, San Diego, U.S.A.</span></div>
<div>
<span style="font-size: xx-small;">5-<span style="white-space: pre;"> </span>Cox, A., Borel, F., Li, W., Brodsky, M. and Meuller, C., “Simultaneous disruption of five serpinA1 genes in mice using CRISPR/Cas9 to generate the first animal model of alpha-1 antitrypsin deficiency”, Poster presented at the American Society of Gene & Cell Therapy 18th Annual Meeting, American Society of Gene & Cell Therapy 18th Annual Meeting, Gene Targeting and Gene Correction II, May 14th 2015, New Orleans, U.S.A.</span></div>
<div>
<br /></div>
</div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-52601989723102466422017-10-24T09:10:00.000-04:002017-10-24T09:10:21.053-04:00Dose rather than concentration<div style="text-align: justify;">
Bronchoprovocation is a pulmonary function test frequently performed in patients as a diagnostic or therapy management tool. It assesses the subject’s level of airway responsiveness following increasing aerosol challenges of methacholine, a direct bronchoconstrictive agent. </div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: justify;">
<a href="https://1.bp.blogspot.com/-Pk3CtkViZEI/WeeUvcLlhuI/AAAAAAAABlI/iIITyCQQx2sUb5LaCAytt_UFA2u6fT9ZACEwYBhgL/s1600/Dose%2Brather%2Bthan%2Bconcentration%2B-%2Bblog%2Bpic%2B1.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="550" data-original-width="682" height="258" src="https://1.bp.blogspot.com/-Pk3CtkViZEI/WeeUvcLlhuI/AAAAAAAABlI/iIITyCQQx2sUb5LaCAytt_UFA2u6fT9ZACEwYBhgL/s320/Dose%2Brather%2Bthan%2Bconcentration%2B-%2Bblog%2Bpic%2B1.png" width="320" /></a>Recently, the European Respiratory Society (ERS), in collaboration with the American Thoracic Society (ATS), updated their guidelines relative to this test. The most significant modification made was the recommendation that the test outcome be expressed in terms of the dose delivered rather than as the concentration of the solution loaded into the nebulizer<sup><span style="font-family: "segoe ui" , sans-serif; line-height: 107%;"><span style="font-size: xx-small;">1</span></span></sup>. The ERS guidelines state that this updated end-point reporting allows for comparable results from different devices or protocols, since the dose concept can account for delivery variations<sup><span style="font-family: "segoe ui" , sans-serif; line-height: 107%;"><span style="font-size: xx-small;">2</span></span></sup>. </div>
<br />
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Methacholine challenge tests are also performed at the pre-clinical level. There, the notion of delivered dose was introduced earlier<sup><span style="font-family: "segoe ui" , sans-serif; line-height: 107%;"><span style="font-size: xx-small;">3</span></span></sup> and researchers who have been using the <a href="http://www.scireq.com/flexivent" target="_blank">flexiVent FX</a> system have known for some time the effectiveness of this now recommended clinical procedure or its impact on study comparison. Indeed, with the push of a button, the operating <a href="http://www.scireq.com/flexivent/flexiware" target="_blank">flexiVent software</a> can automatically generate a delivered dose estimate for each subject and aerosol challenge. The dose calculation is based on specific nebulizer, subject, and system characteristics and imposes no restrictions on the experimental protocol nor does it require additional pieces of equipment. The delivered dose estimate thus offers an important standardization to the preclinical assessment of airway responsiveness that now coincides with the most recent clinical recommendations. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Contact us for more information on the <a href="http://www.scireq.com/flexivent/techniques-and-measurements#delivered_dose_measurement" target="_blank">delivered dose concept</a>. Our application specialists will be happy to answer your questions or assist you to improve your study.</div>
<div style="text-align: justify;">
<br /></div>
<b>Contact Us</b><br />
Phone: 1.514.286.1429 | Toll Free 1.877.572.4737<br />
Email: <a href="mailto:info@scireq.com" target="_blank">info@scireq.com</a><br />
<br />
<br />
<div>
<div>
<b>READ MORE</b></div>
<div>
<span style="font-size: x-small;"><span style="font-family: "segoe ui" , sans-serif; vertical-align: super;">1</span>Coates, Allan L., et al. 2017. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. European Respiratory Journal 49 (5): 1601526.</span></div>
<div>
<span style="font-size: xx-small;"><span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">2</span></span><span style="font-size: x-small;">Coates, Allan L., et al. 2017. The PD 20 but not the PC 20 in a methacholine challenge test is device independent. Annals of Allergy, Asthma & Immunology 118 (4): 508-509.</span></span></div>
<div>
<span style="font-family: "segoe ui" , "sans-serif"; font-size: 11.0pt; line-height: 107%;"></span><span style="font-size: xx-small;"><span style="font-family: "segoe ui" , sans-serif; vertical-align: super;"><span style="font-size: xx-small;">3</span></span><span style="font-size: x-small;">Robichaud, Annette, Liah Fereydoonzad, and Thomas F. Schuessler. 2015. Delivered dose estimate to standardize airway hyperresponsiveness assessment in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 308 (8): L837-L846.</span></span></div>
</div>
<div>
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-59911666458285298752017-10-19T10:19:00.002-04:002017-10-19T10:19:20.728-04:00Great success at JAX Workshop on Phenotyping Mouse Models of Human Lung Disease<div class="MsoNormal">
<div style="text-align: justify;">
<span style="font-family: "segoe ui" , sans-serif;">After a year of absence, the well-established Workshop on Phenotyping Mouse Models of Human Lung Disease returned last week in Bar Harbor, ME. As in the past, SCIREQ was a partner in this year's event, in collaboration with the Jackson Laboratory Educational Program.</span><br />
<span style="font-family: "segoe ui" , sans-serif;"><br /></span></div>
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="MsoNormal">
<div style="text-align: justify;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://4.bp.blogspot.com/-XV2VZBftjh8/Weiz-SPRRwI/AAAAAAAABlU/jDHy79umzZsfXqAQKTIx6Ys_sCNjRRbiACLcBGAs/s1600/Pic2.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="796" data-original-width="764" height="320" src="https://4.bp.blogspot.com/-XV2VZBftjh8/Weiz-SPRRwI/AAAAAAAABlU/jDHy79umzZsfXqAQKTIx6Ys_sCNjRRbiACLcBGAs/s320/Pic2.jpg" width="307" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<span style="font-family: "segoe ui" , sans-serif;">The course, which offers great learning and networking opportunities, contains both a theoretical and a practical part and covers various topics relevant to respiratory research. Two laboratory sessions on lung function measurements are typically included in the event schedule. During these sessions, the participants are divided into small groups, where they can interact with key leaders in the field, such as Dr Wayne Mitzner (John Hopkins Bloomberg School of Public Health) or Dr Lennart K. A. Lundblad (The University of Vermont), while learning about state-of-the-art techniques.</span></div>
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-XpriDp8BCws/Weiz-RCAafI/AAAAAAAABlY/9ONuGcFamx8OPv0HrsH8RBA8ceCqE1sAwCLcBGAs/s1600/Pic%2B1.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1246" data-original-width="1190" height="320" src="https://2.bp.blogspot.com/-XpriDp8BCws/Weiz-RCAafI/AAAAAAAABlY/9ONuGcFamx8OPv0HrsH8RBA8ceCqE1sAwCLcBGAs/s320/Pic%2B1.jpg" width="305" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="MsoNormal">
<div style="text-align: justify;">
<span style="font-family: "segoe ui" , sans-serif;">This renowned scientific event catering to the needs of pre-clinical researchers from around the world was fully attended this year. We will be there next time. We hope you will be there too!</span></div>
</div>
<div class="MsoNormal">
<div style="text-align: justify;">
<span style="font-family: "segoe ui" , sans-serif;"><br /></span></div>
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: justify;">
<span style="font-family: "segoe ui" , sans-serif;">For more information on SCIREQ or its products for respiratory research applications, please visit our website at </span><a href="http://www.scireq.com/" style="font-family: "Segoe UI", sans-serif;">www.scireq.com</a><span style="font-family: "segoe ui" , sans-serif;">.</span></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0tag:blogger.com,1999:blog-1478237573772053730.post-60717922263140056572017-10-18T12:04:00.002-04:002017-10-18T12:04:41.480-04:00Biennale Pneumologie 2017 et CQSR<div style="text-align: justify;">
<span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;">Merci aux organisateurs et à tous les participants de la Biennale
Pneumologie 2017 et du CQSR, qui a eu lieu dans la magnifique ville de Québec.
Nous avons particulièrement apprécié le volet sur la recherche fondamentale
appliquée, où nous avons pu assister à des présentations sur l’asthme, la
fibrose kystique, la SDRA et les MPOC (pour les Québécois) ou BPCO (pour les
Français) </span><span lang="FR-CA" style="font-family: Wingdings; mso-ansi-language: FR-CA;">J</span><span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;"><o:p></o:p></span></div>
<div style="text-align: justify;">
<span lang="FR-CA" style="font-family: Wingdings; mso-ansi-language: FR-CA;"><br /></span></div>
<div style="text-align: justify;">
<span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;">emka TECHNOLOGIES et SCIREQ sont fières de travailler avec les
chercheurs francophones qui étudient sur le système respiratoire et les
maladies cardio-pulmonaires.</span><span lang="FR-CA"> <o:p></o:p></span></div>
<div style="text-align: justify;">
<span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;"><br /></span></div>
<div style="text-align: justify;">
<span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;">Au plaisir de vous revoir à la Biennale 2019.<o:p></o:p></span></div>
<span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;"><br /></span>
<br />
<span lang="FR-CA" style="font-family: "Calibri","sans-serif"; mso-ansi-language: FR-CA;"><b><u>Liens :</u></b></span><br />
<br />
<ul>
<li><a href="https://pq.poumon.ca/cqsr/2017/" style="font-family: Calibri, sans-serif; text-indent: -18pt;">CQSR</a></li>
<li><a href="http://splf.fr/groupes-de-travail/j2r/" style="font-family: Calibri, sans-serif; text-indent: -18pt;">J2R</a></li>
</ul>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-WaK1Ye0Yya0/Wed514ehPLI/AAAAAAAABkQ/AF1dgpy3UcE_3RfP4R3jLFAjRzYry7IxgCEwYBhgL/s1600/Pic%2B1.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="276" data-original-width="603" height="182" src="https://2.bp.blogspot.com/-WaK1Ye0Yya0/Wed514ehPLI/AAAAAAAABkQ/AF1dgpy3UcE_3RfP4R3jLFAjRzYry7IxgCEwYBhgL/s400/Pic%2B1.jpg" width="400" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-_4LrGQ80HXs/Wed53Ddl12I/AAAAAAAABkQ/j0bgQncLirEEGefYHyGtKm936iTiQMTFwCEwYBhgL/s1600/Pic%2B2.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="277" data-original-width="665" height="166" src="https://1.bp.blogspot.com/-_4LrGQ80HXs/Wed53Ddl12I/AAAAAAAABkQ/j0bgQncLirEEGefYHyGtKm936iTiQMTFwCEwYBhgL/s400/Pic%2B2.jpg" width="400" /></a></div>
<div style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;">
<br /></div>
SCIREQ Inchttp://www.blogger.com/profile/03796355448475138593noreply@blogger.com0